VBI Vaccines To Expand Strategic Partnership With Canadian Government; Partnership To Direct CAD$28M Of Funding Remaining Under Original CAD$56M Award To Continue Development Of Proprietary Tech Platforms
Portfolio Pulse from Benzinga Newsdesk
VBI Vaccines has announced an expansion of its strategic partnership with the Canadian government, directing the remaining CAD$28M of the original CAD$56M award towards the continued development of its proprietary technology platforms.
April 02, 2024 | 12:08 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
VBI Vaccines is set to receive the remaining CAD$28M from its original CAD$56M award from the Canadian government to continue developing its proprietary technology platforms.
The continuation of this strategic partnership and the allocation of the remaining CAD$28M towards VBI Vaccines' technology platforms is a positive development for the company. It not only provides financial support but also validates the potential of VBI's proprietary technologies. This news is likely to be viewed positively by investors, potentially leading to an increase in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 90